You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 253 No. 9, March 1, 1985 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Deoxyuridine Suppression Test Identifies Subtle Cobalamin Deficiency in Patients Without Typical Megaloblastic Anemia

Ralph Carmel, MD; Dean S. Karnaze, MD

JAMA. 1985;253(9):1284-1287.


Abstract

Four patients had serum cobalamin levels that were initially thought to be falsely low. None of the patients had the typical hematologic and clinical features of cobalamin deficiency and the three so tested had normal cobalamin absorption and/or gastric function. However, the deoxyuridine suppression test result was abnormal in all four cases. The abnormality was improved by adding cobalamin in vitro but, in three of the four cases, was not corrected and, indeed, was made worse by the addition of methyl tetrahydrofolate. These results established metabolically the presence of cobalamin deficiency. The recently improved cobalamin radioassays may be unmasking some atypical and, heretofore, unappreciated cobalamin-deficiency states (only one of our four patients would have come to attention with the older radioassays). These can be identified with the deoxyuridine suppression test, particularly when specific in vitro additives are included.

(JAMA 1985;253:1284-1287)



Author Affiliations

From the Departments of Medicine (Dr Carmel) and Neurology (Dr Karnaze), University of Southern California School of Medicine, Los Angeles, and the Los Angeles County-USC Medical Center.


Footnotes

Reprint requests to USC School of Medicine, 2025 Zonal Ave, RMR 306, Los Angeles, CA 90033 (Dr Carmel).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

How I treat cobalamin (vitamin B12) deficiency
Carmel
Blood 2008;112:2214-2221.
ABSTRACT | FULL TEXT  

Increased Plasma Methylmalonic Acid Level Does Not Predict Clinical Manifestations of Vitamin B12 Deficiency
Hvas et al.
Arch Intern Med 2001;161:1534-1541.
ABSTRACT | FULL TEXT  

Cobalamin Deficiency in General Practice. Assessment of the Diagnostic Utility and Cost-Benefit Analysis of Methylmalonic Acid Determination in Relation to Current Diagnostic Strategies
Holleland et al.
Clin. Chem. 1999;45:189-198.
ABSTRACT | FULL TEXT  

Neurologic and Evoked Potential Abnormalities in Subtle Cobalamin Deficiency States, Including Deficiency Without Anemia and With Normal Absorption of Free Cobalamin
Karnaze and Carmel
Arch Neurol 1990;47:1008-1012.
ABSTRACT  

Low Serum Cobalamin Levels in Primary Degenerative Dementia: Do Some Patients Harbor Atypical Cobalamin Deficiency States?
Karnaze and Carmel
Arch Intern Med 1987;147:429-431.
ABSTRACT  

Physician Response to Low Serum Cobalamin Levels
Carmel and Karnaze
Arch Intern Med 1986;146:1161-1165.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.